J&J’s Earnings Win Muted By Currency Impact (JNJ)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down 7.4% to $15.2 billion vs. 15.02 billion estimates. Currency was another drag on the company.
As far as the impact of currency, this was sharp. Operational results were down 1.4% and the impact of currency was negative by 6.0%. Operational growth of sales was roughly 3.9%, reflecting a negative currency impact of 11.9%.
Despite the beat on earnings, this marks a 6.7% drop in domestic sales and marks a 8% drop in international sales. Consumer product sales were down 4.5%.
J&J is also backing its annual outlook of $4.45 to $4.55 EPS for 2009. Thomson Reuters has estimates of $4.51.
Shares closed at $57.72 yesterday, and pre-market indications are up over $58.50. Its 52-week trading range is $46.25 to $72.76.
JON C. OGG
JULY 14, 2009
Contact [email protected] for any questions or corrections.


